123 related articles for article (PubMed ID: 32492152)
21. Convergent Mechanistic Features between the Structurally Diverse N- and O-Methyltransferases: Glycine N-Methyltransferase and Catechol O-Methyltransferase.
Zhang J; Klinman JP
J Am Chem Soc; 2016 Jul; 138(29):9158-65. PubMed ID: 27355841
[TBL] [Abstract][Full Text] [Related]
22. Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase.
Li Y; Yang X; Chang M; Yager JD; van Breemen RB; Bolton JL
Chem Biol Interact; 2005 Apr; 152(2-3):151-63. PubMed ID: 15840388
[TBL] [Abstract][Full Text] [Related]
23. 5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase.
Fuller RW; Roush BW
Biochem Pharmacol; 1974 Aug; 23(15):2208-9. PubMed ID: 4416934
[No Abstract] [Full Text] [Related]
24. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
Tsuji E; Okazaki K; Isaji M; Takeda K
J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of catechol O-methyltransferase.
Vidgren J; Svensson LA; Liljas A
Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
[TBL] [Abstract][Full Text] [Related]
26. The reaction mechanism of phenylethanolamine N-methyltransferase: a density functional theory study.
Georgieva P; Wu Q; McLeish MJ; Himo F
Biochim Biophys Acta; 2009 Dec; 1794(12):1831-7. PubMed ID: 19733262
[TBL] [Abstract][Full Text] [Related]
27. Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models.
Taskinen J; Ethell BT; Pihlavisto P; Hood AM; Burchell B; Coughtrie MW
Drug Metab Dispos; 2003 Sep; 31(9):1187-97. PubMed ID: 12920175
[TBL] [Abstract][Full Text] [Related]
28. Structural and biochemical characterization of Rv0187, an O-methyltransferase from Mycobacterium tuberculosis.
Lee S; Kang J; Kim J
Sci Rep; 2019 May; 9(1):8059. PubMed ID: 31147608
[TBL] [Abstract][Full Text] [Related]
29. Catechol O-methyltransferase.
Borchardt RT
Methods Enzymol; 1981; 77():267-72. PubMed ID: 7329304
[No Abstract] [Full Text] [Related]
30. Ultraviolet resonance Raman study of drug binding in dihydrofolate reductase, gyrase, and catechol O-methyltransferase.
Couling VW; Fischer P; Klenerman D; Huber W
Biophys J; 1998 Aug; 75(2):1097-106. PubMed ID: 9675211
[TBL] [Abstract][Full Text] [Related]
31. Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors.
Ellermann M; Lerner C; Burgy G; Ehler A; Bissantz C; Jakob-Roetne R; Paulini R; Allemann O; Tissot H; Grünstein D; Stihle M; Diederich F; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2012 Mar; 68(Pt 3):253-60. PubMed ID: 22349227
[TBL] [Abstract][Full Text] [Related]
32. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.
Zhu BT
Curr Drug Metab; 2002 Jun; 3(3):321-49. PubMed ID: 12083324
[TBL] [Abstract][Full Text] [Related]
33. The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols.
Sak K
Drug Metab Rev; 2017 Feb; 49(1):56-83. PubMed ID: 27826992
[TBL] [Abstract][Full Text] [Related]
34. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
[TBL] [Abstract][Full Text] [Related]
35. Effects of Active-Site Modification and Quaternary Structure on the Regioselectivity of Catechol-O-Methyltransferase.
Law BJ; Bennett MR; Thompson ML; Levy C; Shepherd SA; Leys D; Micklefield J
Angew Chem Int Ed Engl; 2016 Feb; 55(8):2683-7. PubMed ID: 26797714
[TBL] [Abstract][Full Text] [Related]
36. Elucidation of the methyl transfer mechanism catalyzed by chalcone O-methyltransferase: a density functional study.
Cui FC; Pan XL; Liu W; Liu JY
J Comput Chem; 2011 Nov; 32(14):3068-74. PubMed ID: 21815175
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
Bai HW; Shim JY; Yu J; Zhu BT
Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
[TBL] [Abstract][Full Text] [Related]
38. The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase.
Cuyàs E; Verdura S; Lozano-Sánchez J; Viciano I; Llorach-Parés L; Nonell-Canals A; Bosch-Barrera J; Brunet J; Segura-Carretero A; Sanchez-Martinez M; Encinar JA; Menendez JA
Food Chem Toxicol; 2019 Jun; 128():35-45. PubMed ID: 30935952
[TBL] [Abstract][Full Text] [Related]
39. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
